-
1
المؤلفون: Rosie Bradley, Jeremy Braybrooke, Richard Gray, Robert Hills, Zulian Liu, Richard Peto, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn Taylor, Stewart Anderson, Richard Gelber, Luca Gianni, William Jacot, Heikki Joensuu, Alvaro Moreno-Aspitia, Martine Piccart, Michael Press, Edward Romond, Dennis Slamon, Vera Suman, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Fran Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Yaochen Wang, John Crown, Evandro de Azambuja, Suzette Delaloge, Helena Fung, Charles Geyer, Marc Spielmann, Pinuccia Valagussa, Kathy Albain, Rodrigo Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith Bliss, Etienne Brain, Lisa Carey, Robert Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, Michael Gnant, Matthew Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Vinod Raina, Daniel Rea, Meredith Regan, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Kathleen I Pritchard, Sandra M Swain
المساهمون: Bradley, R, Braybrooke, J, Gray, R, Hills, R, Liu, Z, Peto, R, Dodwell, D, McGale, P, Pan, H, Taylor, C, Clarke, M, MacKinnon, E, Early Breast Cancer Trialists’ Collaborative group (EBCTCG)
المصدر: The Lancet. Oncology
The lancet oncology
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) 2021, ' Trastuzumab for early-stage, HER2-positive breast cancer : a meta-analysis of 13 864 women in seven randomised trials ', The Lancet Oncology, vol. 22, no. 8, pp. 1139-1150 . https://doi.org/10.1016/S1470-2045Test(21)00288-6مصطلحات موضوعية: Oncology, medicine.medical_specialty, Receptor, ErbB-2, medicine.medical_treatment, Breast cancer mortality, Breast Neoplasms, breast cancer, Breast cancer, Antineoplastic Agents, Immunological, Trastuzumab, HER2 Positive Breast Cancer, Internal medicine, medicine, Humans, Stage (cooking), skin and connective tissue diseases, Chemotherapy, business.industry, adjuvant therapy, Articles, medicine.disease, Meta-analysis, Female, Human medicine, business, breast cancer, adjuvant therapy, trastuzumab, Adjuvant, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d82494828596b0011685b9eb25b23e93Test
http://europepmc.org/articles/PMC8324484Test -
2
المؤلفون: Sara A. Hurvitz
المصدر: Lancet Oncol
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Treatment choices, Receptor, ErbB-2, Patient Selection, MEDLINE, Retrospective cohort study, Breast Neoplasms, Prognosis, Article, Text mining, HER2 Positive Breast Cancer, Internal medicine, Medicine, Humans, business, Retrospective Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de9ad6ca87205b53a264253386393d65Test
https://pubmed.ncbi.nlm.nih.gov/33152285Test -
3
المؤلفون: Amanda I Adler, Zoe Garrett, Elisabeth George, Martyn J Burke
المصدر: The Lancet. Oncology. 14(11)
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Everolimus, business.industry, Endocrine therapy, HER2 negative, medicine.disease, Nice guidance, chemistry.chemical_compound, Breast cancer, Exemestane, chemistry, Hormone receptor, Internal medicine, medicine, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86d7656ccdc1ecdb355d433dd033b72Test
https://pubmed.ncbi.nlm.nih.gov/29606380Test -
4
المؤلفون: Xavier Pivot, David G. Cox
المصدر: The Lancet. Oncology. 19(2)
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Pyridines, medicine.medical_treatment, MEDLINE, Breast Neoplasms, Antibodies, Monoclonal, Humanized, Piperazines, 03 medical and health sciences, 0302 clinical medicine, Trastuzumab, HER2 Positive Breast Cancer, Internal medicine, medicine, Humans, 030212 general & internal medicine, Fulvestrant, Neoadjuvant therapy, biology, business.industry, Treatment development, Neoadjuvant Therapy, 030220 oncology & carcinogenesis, Monoclonal, biology.protein, Antibody, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3bedc1b9838fd9ac61507138c469c28Test
https://pubmed.ncbi.nlm.nih.gov/29326029Test -
5
المؤلفون: Aju Mathew, Adam Brufsky
المصدر: The Lancet. Oncology. 18(4)
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Receptor, ErbB-2, MEDLINE, Cancer, Breast Neoplasms, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Breast cancer, 030220 oncology & carcinogenesis, Internal medicine, HER2 Positive Breast Cancer, medicine, Humans, Stage (cooking), business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3967f4892ba2d5a0999f7e19a310117eTest
https://pubmed.ncbi.nlm.nih.gov/28238593Test -
6
المؤلفون: Hajime Uno, Lee-Jen Wei, Takahiro Hasegawa
المصدر: The Lancet. Oncology. 17(5)
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Receptor, ErbB-2, Hazard ratio, Time loss, Breast Neoplasms, Trastuzumab, Placebo, 03 medical and health sciences, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Internal medicine, Mean Survival Time, HER2 Positive Breast Cancer, Neratinib, medicine, Quinolines, Humans, In patient, Female, 030212 general & internal medicine, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f40dc2bbff8c853e80ca71cb4fba2810Test
https://pubmed.ncbi.nlm.nih.gov/27301039Test -
7
المؤلفون: Hope S. Rugo, A. Jo Chien
المصدر: The Lancet. Oncology. 17(3)
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Receptor, ErbB-2, MEDLINE, Breast Neoplasms, Trastuzumab, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Breast cancer, 030220 oncology & carcinogenesis, Internal medicine, HER2 Positive Breast Cancer, medicine, Humans, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::982e912dc90271df9703a34989648806Test
https://pubmed.ncbi.nlm.nih.gov/26874901Test -
8
المؤلفون: Thomas Bachelot, Véronique Diéras, Marta Jimenez, Claire Cropet, Mario Campone
المصدر: The Lancet. Oncology. 14(1)
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Brain Neoplasms, Breast Neoplasms, Lapatinib, Deoxycytidine, Text mining, Internal medicine, HER2 Positive Breast Cancer, Quinazolines, Medicine, Humans, Female, Fluorouracil, business, Capecitabine
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb8987c2afa40879d5dd8bb0aef06a5Test
https://pubmed.ncbi.nlm.nih.gov/23276370Test -
9
المؤلفون: Brian R. Smith, Brian Leyland-Jones
المصدر: The Lancet. Oncology. 12(3)
مصطلحات موضوعية: Gynecology, Oncology, medicine.medical_specialty, Poor prognosis, business.industry, Receptor, ErbB-2, MEDLINE, Breast Neoplasms, medicine.disease, Prognosis, Discontinuation, Breast cancer, Trastuzumab, Internal medicine, HER2 Positive Breast Cancer, Biomarkers, Tumor, Medicine, Humans, In patient, Female, skin and connective tissue diseases, business, Human Epidermal Growth Factor Receptor 2, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e99a344baad6f12ff4010de005e7952Test
https://pubmed.ncbi.nlm.nih.gov/21376291Test